The first-ever adaptive clinical trial for Australians living with MS will seek to reverse neurological damage caused by progressive multiple sclerosis.
With an initial $4 million in funding, the trial, commencing in January 2024, will enable researchers to investigate the potential benefits of several medications simultaneously, giving hope to the cohort of people living with one of the most debilitating forms of MS and who currently have extremely limited treatment options.
https://www.news-medical.net/news/20231 ... rosis.aspx